This editorial refers to the article published by Sachpekidis et al 1 titled 'Equilibrium radionuclide angiography (ERNA): intra-and interobserver repeatability and reproducibility in the assessment of cardiac systolic and diastolic function' on the Journal of Nuclear Cardiology. The objective of this study was to assess the intra-and interobserver agreement in assessing the systolic and diastolic function with ERNA. The authors analyzed thirty-two adults underwent baseline and repeat ERNA. An experienced and a trainee operator analyzed the data by assigning regions of interest manually, fully automatically, and semi-automatically. The Bland-Altman statistic was used to assess the repeatability (two different assessments of a single acquisition) and reproducibility (assessments of two different acquisitions). According to the obtained results, the Authors concluded that: 'A good repeatability but a moderate reproducibility was found in the assessment of the left ventricular ejection fraction (LVEF). Less good were the findings in the assessment of diastolic function. The results also depended on the software tool'.
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This article provides interesting information about the intra-and interobserver repeatability and reproducibility in the assessment of cardiac systolic and diastolic function. Despite the fact that in the conclusions of this study the authors say that ERNA has a moderate reproducibility in the assessment of the LVEF; ERNA continues to be one of the best imaging techniques for the analysis of ventricular function. The analysis of the variability in the measurements of a technique is complex and not only depends on of the intra-and interobserver variability, but of other variabilities that are not generally taken into account, such as the day-to-day variability of the phenomenon studied, the variability of the pathology, age, gender, etc. In addition to this research study, it has a very heterogeneous population (men = 20, women = 12, heart failure = 13, cardiotoxic chemotherapy = 12, different degree of systolic dysfunction) in a small (n = 31) number of patients. Table 1 shows the reproducibility, and inter-and intra-observer variations of ERNA according to different acquisition methodology to evaluate left and right ventricular function. [1] [2] [3] [4] [5] [6] [7] ERNA has a high reproducibility, very low inter-or intra-observer variability, and high precision; it has been shown to be accurate when compared to other modalities and has strong early data that demonstrated efficacy in guiding the safety of treatment regimens, and it continues to be widely used for routine clinical monitoring. 8 This information is consistent with the comments of Sachpekidis et al. 9 in a previous review. Table 1 . was slightly lower than that with planar RNA. Both were substantially lower than that with SPECT-QBS. The within subject coefficient of variation for SPECT-QBS was estimated to be 3.835 times higher than that for planar RNA and 6.322 times higher than that for SPECT-35%
Clements et al There are many different nuclear techniques 11 for measuring ventricular function including ERNA referred to also as gated bloodpool scan or multigated angiography (MUGA), first-pass radionuclide ventriculography, gated single-photon computed tomography (SPECT) with myocardial perfusion imaging, SPECT ERNA, gated PET MPI, gated PET 18 F-FDG, and gated first-pass 18 F-FDG PET. 11, 12 Is true that studies of quantitative echocardiography, cardiac magnetic resonance and cardiac computed tomography, to assess ventricular function, are becoming more frequent. Although this does not mean that these imaging techniques will replace ERNA as they do not have a better ventricular functional assessment; ERNA continues to be widely used for routine clinical monitoring. 8 At present, conventional planar ERNA has recently gained less favor due to the growing concern of radiation exposure (740 MBq; 5.18 mSV) to patients.
13,14 As Giubbini et al 11 explain, planar imaging is limited by the overlap of different cardiac structures affecting the calculation of LVEF, especially in the presence of mitral regurgitation, the valvular function cannot be explored, and the volumes of heart chambers are only roughly determined. Though, when compared to planar image acquisition, SPECT ERNA acquired with high-sensitivity CZT cameras can be done with lower radiation dose, faster image acquisition time, and improved reproducibility. 4, 8, 11, 15 Several studies have been published indicating that tomographic MUGA as a potential replacement for the planar MUGA. 4, 5, 16, 17 In addition, there may be a tendency to decrease the number of ERNA. For example, Beller 18 commented in an editorial that, at the University of Virginia, a total of 3302 SPECT studies, and 347 MUGA studies, were per- Currently, ERNA is used to: (A) quantify left ventricular and right stroke volumes and ejection fractions in patients with moderate to severe tricuspid regurgitation, 19 (B) obtain measures of dyssynchrony to predict outcomes in heart failure patients, [20] [21] [22] [23] (C) assess left ventricular function and mechanical dyssynchrony in patients with right ventricular outflow tract pacing and right ventricular apical pacing, 24 (D) study the accuracy of automated LVEF measurements in the presence of large perfusion defects in a myocardial infarction, in which the estimation of endocardial borders might be expected to be difficult because of reduced or absent counts, requiring some degree of extrapolation with a geometric model, 25, 26 (Figure 2 ).
Furthermore, in oncologic patients treated with chemotherapy, ERNA is a good imaging technique to detect systolic dysfunction through left and right ventricular ejection fraction analysis. Small changes in LVEF may be important in clinical decision-making, 8, 11 and added to low inter-and intra-observer variability of ERNA, it is ideal for cardiac monitoring cardiac conditions. 8 Thus, ERNA serves to guide therapy of oncologic patients. 8 In addition, the measures of diastolic left ventricular dysfunction by means of ERNA can precede systolic dysfunction in chemotherapies and provide a more sensitive and specific predictor of longterm chemotherapy-induced heart failure. 35 The occurrence of right ventricular dysfunction is a well-known indicator of poor prognosis in patients with chronic cardiopulmonary disease. 36 Selimovic et al 36 performed a retrospective analysis of lung transplant candidates (n = 152) who had undergone ERNA, to determine baseline and exercise right ventricular ejection fraction. The authors concluded that in lung transplant candidates, right ventricular function during exercise is a stronger predictor of outcome than right ventricular function at rest. Right ventricular ejection fraction during exercise assessed by ERNA could be incorporated into priority-based allocation algorithms for lung transplant.
CONCLUSION
In conclusion, ERNA continues to be a valid method for the analysis, validation and monitoring of left and right ventricular systolic and diastolic function in several clinical settings. It is a reference standard for Table 2 continued 
